These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 9833620)
21. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia]. Song SQ; Zhang GN Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175 [TBL] [Abstract][Full Text] [Related]
22. [Methotrexate in gynecologic oncology]. Isonishi S; Terashima Y Gan To Kagaku Ryoho; 1996 Dec; 23(14):1896-900. PubMed ID: 8978793 [TBL] [Abstract][Full Text] [Related]
23. The management of gestational trophoblastic tumors with etoposide, methotrexate, and actinomycin D. Soto-Wright V; Goldstein DP; Bernstein MR; Berkowitz RS Gynecol Oncol; 1997 Jan; 64(1):156-9. PubMed ID: 8995566 [TBL] [Abstract][Full Text] [Related]
25. Conservative Chemotherapy in Gestational Trophoblastic Disease: Experience With Etoposide, Methotrexate, and Dactinomycin Chemotherapy. Byun SW; Park TC; Bae SN Int J Gynecol Cancer; 2016 May; 26(4):790-5. PubMed ID: 27057813 [TBL] [Abstract][Full Text] [Related]
26. Plasma methotrexate levels in patients receiving etoposide, methotrexate, actinomycin, cyclophosphamide, and vincristine (EMA-CO) chemotherapy for trophoblastic neoplasia. Kohorn EI Gynecol Oncol; 1993 Sep; 50(3):300-4. PubMed ID: 8406191 [TBL] [Abstract][Full Text] [Related]
27. Management of drug resistant gestational trophoblastic neoplasia. Patel SM; Desai A J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341 [TBL] [Abstract][Full Text] [Related]
28. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors. Matsui H; Suzuka K; Iitsuka Y; Seki K; Sekiya S Gynecol Oncol; 2000 Jul; 78(1):28-31. PubMed ID: 10873405 [TBL] [Abstract][Full Text] [Related]
29. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease. Schink JC; Singh DK; Rademaker AW; Miller DS; Lurain JR Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977 [TBL] [Abstract][Full Text] [Related]
30. EMA-CO chemotherapy for high-risk gestational trophoblastic neoplasia: a clinical analysis of 54 patients. Lu WG; Ye F; Shen YM; Fu YF; Chen HZ; Wan XY; Xie X Int J Gynecol Cancer; 2008; 18(2):357-62. PubMed ID: 17711444 [TBL] [Abstract][Full Text] [Related]
31. [Treatment of patients with trophoblastic tumors in the Academic Medical Center: 31 patients in 10 years, 1983-1992]. Laan R; Bakker P; Lammes FB Ned Tijdschr Geneeskd; 1995 Sep; 139(36):1829-34. PubMed ID: 7477506 [TBL] [Abstract][Full Text] [Related]
32. Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia. Lybol C; Thomas CM; Blanken EA; Sweep FC; Verheijen RH; Westermann AM; Boere IA; Reyners AK; Massuger LF; van Hoesel RQ; Ottevanger PB Eur J Cancer; 2013 Mar; 49(4):860-7. PubMed ID: 23099004 [TBL] [Abstract][Full Text] [Related]
33. Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia. Lurain JR; Schink JC J Reprod Med; 2012; 57(5-6):219-24. PubMed ID: 22696816 [TBL] [Abstract][Full Text] [Related]
34. [Methotrexate combined chemotherapy for chemorefractory gestational trophoblastic tumour]. Xiang Y; Yang X; Han S Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):97-100. PubMed ID: 11263207 [TBL] [Abstract][Full Text] [Related]
35. Successful resolution of persistent trophoblastic disease after partial mole with the EMA-CO regimen. Dgani R; Zalel Y; Biran H; Blickstein I; Caspi B; Weissman A; Shoham Z Eur J Obstet Gynecol Reprod Biol; 1994 Mar; 54(1):77-9. PubMed ID: 7519153 [TBL] [Abstract][Full Text] [Related]
36. Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease. Remission rates and drug toxicities. Matsui H; Iitsuka Y; Seki K; Sekiya S Gynecol Obstet Invest; 1998; 46(1):5-8. PubMed ID: 9692333 [TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics of gestational trophoblastic disease at a single institute. Alici S; Eralp Y; Saip P; Argon A; Basaran M; Topuz E; Aydiner A Tohoku J Exp Med; 2002 Jun; 197(2):95-100. PubMed ID: 12233789 [TBL] [Abstract][Full Text] [Related]
39. Pregnancy after EMA/CO for gestational trophoblastic disease: a report from The Netherlands. Lok CA; van der Houwen C; ten Kate-Booij MJ; van Eijkeren MA; Ansink AC BJOG; 2003 Jun; 110(6):560-6. PubMed ID: 12798472 [TBL] [Abstract][Full Text] [Related]
40. A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in "poor prognosis" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study. Curry SL; Blessing JA; DiSaia PJ; Soper JT; Twiggs LB Obstet Gynecol; 1989 Mar; 73(3 Pt 1):357-62. PubMed ID: 2536911 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]